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Abstract
Hearing loss causes severe alterations in social function and daily communications. 
Cochlear device implantation (CDI) is the only beneficiary method for auditory rehabili-
tation in patients with severe to profound sensorineural hearing loss (SNHL). Regarding 
a report in 2014, over 300,000 people had received cochlear implants throughout the 
world since December 2012 among which about 60,000 were adults and 40,000 were chil-
dren in the United States. In this chapter, we discuss the history, origin, mechanism of 
action, and type of cochlear implants, as well as method of surgery and complications.
Keywords: cochlear implantation, hearing loss, complications, clinical applications, 
surgical technique, epidemiology
1. History and introduction
Most of the patients with significant social dysfunction due to hearing loss can be treated by 
nonsurgical interventions. Many ways such as selective seating closer or with the better ear 
near important sound sources or using hearing aids can be utilized for these situations [1].
Cochlear device implantation (CDI) is the only beneficiary method for auditory rehabilita-
tion in patients with severe to profound sensorineural hearing loss (SNHL). Regarding a 
report in 2014, over 300,000 people had received cochlear implants throughout the world 
since December 2012, among which about 60,000 were adults and 40,000 were children in the 
United States [2].
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A 60-year-old history protects cochlear implantation technology, which has experienced mul-
tiple changes in devices and speech processing strategies. It was about 200 years ago when 
Alessandro Volta described the early auditory percepts induced by applying a large voltage 
between his own ears in 1790 [3–6]. Further investigations by Weaver and Bray were focused 
and resulted in this concept that it might be possible to generate electrical signals mimicking 
auditory input stimulus [7].
In 1957, an electrode with receiver coil was successfully implanted for a patient with resected 
cochlear nerve due to cholesteatoma, which was able to stimulate the apparatus for months, 
and shockingly, the patient had sound awareness and simple word recognition [8–10]. 
Following Djourno and Eyries, House started his work in the early 1960s who implanted 
simple wires, wires with ball electrodes, and even simple arrays into the scala tympani, which 
finally led into production of implantable device in 1972; this was a beginning point for clini-
cal trials [3, 11].
At the beginning, there was a resistance from scientific community especially neurophysi-
ologists and otologists against CI; however, the national institute of health (NIH) approved 
the use of electrical stimulation of auditory nerves as a rehabilitation method in 1977, while 
evaluating the outcome in patients with single channel implants [3, 4, 12, 13].
Multichannel CIs were produced in greater numbers due to the food and drug administration 
(FDA) approval because of their ability of open-set word recognition and better frequency 
spectrum percepts [3, 6, 14]. Another remarkable progress was occurred in 1991, while contin-
uous interleaved sampling (CIS) strategy was introduced, which developed improved open-
set word recognition in comparison with previous analogue methods, so that all currently 
available strategies are based on CIS [15].
2. Structure and mechanism of action
Sensory hair cells within the cochlea have the responsibility for transforming sound vibration 
to neural signal in healthy individuals; then, the signal continues its way to auditory cortex 
through cochlear nerve. Cochlear implants take the place of these cells using electrodes which 
stimulate the nerve fiber electrically. Figure 1 illustrates a cochlear implant device. Common 
cochlear implants have two parts: external component as a hearing aid and internal compo-
nent which is surgically inserted in mastoid [16].
The external part is consisted of three parts: a microphone for gathering sounds, a speech 
processor analyzing and encoding sound into a digital code, and a magnetic headpiece which 
transmits coded signals by a transcutaneous radiofrequency link to the internal part.
The internal part has a receiver stimulator which receives and decodes the data and conducts 
decoded signal to the electrode array. In the next step, there is a flexible silicone carrier, which 
has variable number of electrodes. The remaining cochlear nerve fibers are stimulated by the 
electrode array, which is surgically implanted in scala tympani of the cochlea.
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3. Types of cochlear implants
3.1. Totally implantable cochlear implants
Currently available implants have an external part and need patients to wear it consisted of an 
external microphone, processor, and transmitting coil for empowering the electrode, which 
needs a dry and stable environment. Thus, development of totally implantable cochlear 
implants that make the whole system available underneath the skin is a new area of research. 
There are several challenges and requirements in the way of this progress including a tiny and 
sensitive microphone with ability to filter the endogenous noises, as well as a rechargeable 
battery with appropriate long life. There is a report of three patients with totally implantable 
cochlear implants [17].
3.2. Unilateral or bilateral cochlear implantation
Unilateral cochlear implantation was the only option offered at the beginning. Later, it was ques-
tioned if the patients would take more benefits from bilateral cochlear implants. Surprisingly, 
it was revealed that patients with bilateral cochlear implantation show better speech percep-
tion and improvement in “hearing in noise.” Also, these patients showed a significantly better 
sound localization in comparison with their single-side implantation condition [18, 19].
Figure 1. Different parts of cochlear implant (source: NIH/NIDCD https://www.nidcd.nih.gov/health/cochlear-implants).
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Previous studies have concluded that there is no significant difference for audiologic out-
comes between unilateral and bilateral cochlear implantation regarding surgical timing, as 
both ears can be implanted simultaneously or sequentially. Adult studies have shown that 
the second ear matches the first ear performance at 6 months [20]. The story has a difference 
when it comes to children, as it has been concluded that patients with simultaneous bilateral 
cochlear implantation have improved speech recognition and language when compared to 
children who were implanted sequentially [21].
The cost-effectiveness of bilateral cochlear implantation has remained controversial despite 
evident advantages of binaural stimulation. A Canadian study has reported that cochlear 
implantation is cost-effective in adults compared to no implantation; however, sequential 
bilateral cochlear implantation has a slight superiority in comparison with unilateral implan-
tation [22]. Other studies have approved cost effectiveness of bilateral simultaneous pediatric 
implantation and unilateral adult cochlear implantation, although they have not approved 
cost-effectiveness of bilateral sequential pediatric implantation and bilateral (sequential or 
simultaneous) adult implantation [23].
4. Candidacy and patient selection
Selecting the right patient is the building block of a successful cochlear implantation. Therefore, 
a complete medical and audiologic workup is needed for evaluating candidacy of cochlear 
implantation and to make sure that the patient can tolerate anesthesia and surgical process. 
Patients are considered to take benefit from CI when they suffer from bilateral moderate to pro-
found sensorineural hearing loss and when hearing aids cannot help them [24]. A combination 
of objective and subjective hearing tests is conducted to accurately identify the degree of hearing 
loss within audiometric frequencies. Currently available guidelines mention that children up to 
2 years of age should have a bilateral profound sensorineural hearing loss, which is indicated 
by a pure tone audiometry (PTA) more than 90 dBHL for 500, 1000, and 2000 Hz frequencies, 
while patients older than 2 years of age should have bilateral sever to profound SNHL indicated 
by PTA more than 75 dBHL for 500, 1000, and 2000 Hz frequencies [25, 26]. Preoperative speech 
and language evaluation has the same importance for decision making regarding rehabilitation 
strategies and programs, as well as appropriateness of auditory performance, speech produc-
tion, and mode of communication. Hearing loss is categorized to prelingual, postlingual, and 
perilingual types based on the time of onset. In prelingually deaf patients, hearing impairment 
occurs before gaining speaking skills, which is usually before 2 years of age, while it occurs after 
gaining complete speaking skills in postlingual patients which is usually after age of 5 years. In 
perilingual patients, hearing impairment occurs when some speaking skills are gained but are 
not completed usually between 2 and 5 years of age [16].
In addition, preoperative imaging and auditory testing are needed. Imaging modalities such 
as computed tomography (CT) scan, for assessing temporal bone, and magnetic resonance 
imaging (MRI), for evaluating brain anatomy and ruling out abnormalities of cochlear nerve, 
are conducted [15]. After scheduling patient for surgery, pneumococcal vaccines are adminis-
tered according to FDA guidelines.
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Current contraindications for cochlear implantation are two absolute and relative categories. 
Absence of cochlear development, deafness due to lesions of the central auditory pathway, 
and massive cochlear ossification that prevents electrode insertion are among absolute contra-
indications. Relative contraindications include aplasia of the acoustic nerve and medical con-
ditions or developmental delays that would severely limit participation in aural rehabilitation.
5. Surgery
Cochlear implantation procedure is performed under general anesthesia associated with 
facial nerve monitoring. Surgeon needs to expose the mastoid, so a postauricular incision is 
made and soft tissue is dissected; latter, the surgeon makes a subperiosteal pocket for place-
ment of implant magnet. A cortical mastoidectomy is performed associated with finding 
landmarks of temporal bone, such as incus, tegmen tympani, lateral semicircular canal, and 
sigmoid sinus. Then, the surgeon opens the facial recess, which is surrounded by chorda tym-
pani, facial nerve, and incus buttress as its boundaries to identify the round window niche 
through the recess.
There are different methods for accessing scala tympani after finding the round window; in 
cochleostomy, the surgeon drills a separate hole and the anterior limit of the round window in 
extended cochleostomy. The implant is inserted into the cochlea, once the cochlea is opened. 
For making sure of the proper function of implant, an integrity test is performed by an audi-
ologist at the end of the procedure. X-ray radiography is used to ensure proper location of 
cochlear implant by some surgeons. At the end, the patient is discharged the same day, and 
cochlear implant is usually activated 2–4 weeks postoperatively.
6. Complications
Cochlear implantation is generally a safe performed surgical procedure throughout the world 
with globally estimated complication rate of 16% [18]. Requiring additional surgery or cochlear 
explantation is categorized as major, and complications needing conservative medical man-
agement are classified as minor complications. Now, complication rates are decreasing due 
to improved experience, using smaller incisions and improvements in designing devices, and 
are generally calculated to be 11.8% for minor and 3.2% for major complications [27].
Infection is one of the most important major complications of cochlear implantation. Skin 
infection and acute otitis media are the most common type of implant-related infections rang-
ing from 1 to 12% in the literature. Otitis media and soft tissue infection increase the risk of 
cochlear implant removal if leading to receiver stimulator infection. Also, it has been reported 
that cochlear implantation increases the risk of bacterial meningitis as 30-fold greater than gen-
eral population; however, dawn of vaccination has made these cases sporadic [28]. Facial nerve 
palsy is another major complication of cochlear implantation, which is estimated to occur in 
0.7% of cases due to heat induced by drill, cochleostomy, or reactivation of herpes virus as a 
result of surgery stress [29]. Finally, device failure is another major complication of cochlear 
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implantation occurring in 2.5–6% of cases [18, 27]. Vestibular symptoms, such as vertigo and 
disequilibrium, are present in about one-third of patients postoperatively and are believed to 
last for more than 1 week after surgery. Most of these symptoms are resolved in weeks; how-
ever, patients over 70 years of age are more likely to have permanent vestibular weakness [30].
7. Hearing after cochlear implantation
Acoustic hearing remains preserved in more than half of the patients after cochlear implanta-
tion; however, previously, it was believed that insertion of electrode into the cochlea destroys 
the natural mechanism of hearing [31]. Preserving physiologic pathway of hearing has several 
advantages such as ability to localize the sound, recognize the speech, and hear in complex 
listening environments [32]. A variety of factors and approaches have been considered for 
improving hearing preservation after cochlear implantation. Previous studies have reported 
that full electrode insertion makes the hearing preservation possible; however, electrode 
insertion depth and length are determining factors for intracochlear trauma [24, 33].
Studies believe that the most hearing preservation achieves when the electrode is entirely 
located in scala tympani [34]. The most appropriate surgical approach has remained contro-
versial; some previous studies have mentioned that there is no significant difference between 
round window and cochleostomy approaches regarding hearing outcomes [35, 36], while 
others reported that each method is superior for maximizing atraumatic scala tympani inser-
tion. Eventually, preoperative prescription of steroids and steroid-eluting implants have been 
reported to improve hearing preservation up to 1 year from implantation [32].
In another retrospective analysis of cochlear implanted patients, researchers investigated 
the impact of related factors on hearing preservation. They reported an overall preservation 
likelihood of 39% for patients operated by refined soft surgery technique with a higher con-
servation rate at low frequencies when compared to high frequencies [37]. Age at the time 
of implantation, etiology of deafness, side of implant, electrode array model, and insertion 
technique, as well as type of cochleostomy, are investigated factors, which are considered to 
possibly affect hearing preservation; however, there are a variety of opinions on their effects, 
and further studies are required for conclusive results [36, 38–52].
8. Other applications of cochlear implant
8.1. Cochlear implantation for single-sided sensorineural hearing loss
Recently, a new topic has come up about cochlear implantation in setting of single-sided 
sensorineural hearing loss [53]. So far, options such as hearing aids, bone-anchored implants, 
and contralateral routing of signal (CROS) devices were applied for single-side deaf patients. 
While these options improve hearing by healthy ear, cochlear implantation restores hearing 
by deaf ear. Sound localization is a special challenge for patients with unilateral hearing loss. 
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A proper localization involves a good bilateral hearing and sound stimulation, as well as 
intraaural time differences, which allow complex processing of sounds. Recent studies have 
mentioned some advantages for cochlear implantation in unilateral hearing loss, and some 
has reported a better sound localization in comparison with bone-anchored implants [54]. 
Additionally, it has been shown that cochlear implants resolve tinnitus up to an acceptable 
extent in patients with single-sided deafness and may improve speech perception [34, 55].
8.2. Hybrid cochlear implants
A hybrid cochlear implant was developed by Gantz et al. with the aim of preserving residual 
hearing, which has only 10 mm of height [56]. This provides the possibility for stimulating the 
region responsible for high-frequency hearing in cochlea without stimulating regions respon-
sible for low frequency hearing. Primary studies have revealed that hybrid implant application 
is associated with better hearing preservation and increased speech perception [35, 36, 57, 58]. 
In addition to the comparable performance of hybrid implants with conventional ones, 
patients with hybrid implants had improved music appreciation as a result of acoustic and 
electrical stimulation combination [56, 57]. Replacement of hybrid implant with full-length 
implant in a progressive hearing loss improves hearing and word recognition; however, it is 
associated with a notable additional cost [59, 60].
8.3. Cochlear implantation and Meniere’s disease
Cochlear implantation has been utilized for Meniere’s disease, a condition consisted of epi-
sodic attacks of tinnitus, hearing loss, and debilitating vertigo spells. Previous studies have 
shown resolution of related symptoms after cochlear implantation in Meniere’s disease 
patients, although the hearing outcomes are not as acceptable as patients implanted for other 
reasons [61, 62].
9. Prospective of cochlear implantation
So far, some in vitro and animal studies have been conducted to resolve the hearing impair-
ment problem using regenerative medicine; nevertheless, cochlear implantation remains as the 
most effective current treatment method. Further efforts are being put to cochlear implantation 
technology field in order to improve understanding speech in noise and music appreciations.
Abbreviations
CI cochlear implant
CROS contralateral routing of signal
dBHL decibels hearing level
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Hz Hertz; unit of frequency
PTA pure tone audiometry
SNHL sensory-neural hearing loss
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